Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In the combination group, the utilization of GLP-1 RA included liraglutide (13.51%), semaglutide (59.46%), dulaglutide (16.22%), and lixisenatide (10.81%), whereas the use of SGLT2 inhibitors comprised dapagliflozin (40.54%) and empagliflozin (59.46%)
Data were expressed as mean standard deviation, and the significance of differences between group was reflected by the P-value
or foods that contain water, such as soups and gelatin, and skip sweet, sugary foods and drinks, and avoid or limit alcohol intake
Vitamin b12, or cobalamin, is a cofactor the body cannot manufacture
US$ 20.40
US$ 21.64
US$ 21.46
US$ 24.38
US$ 29.29
